Lauretta Brown Lauretta Brown is the Register’s Washington-based staff writer.
WASHINGTON — Pro-life advocates and physicians are warning of serious risks to women arising from the Biden administration’s Dec. 16 permanent lifting of in-person dispensing requirements on the abortion pill mifepristone, which allows for widespread at-home abortions through telemedicine.
The FDA’s move “puts countless women and unborn children in danger,” Sue Liebel, policy director at the pro-life Susan B. Anthony List, warned. “Women who take chemical abortion pills are significantly more at risk of serious complications and more likely to require a visit to the emergency room.”…